Strategic Blueprint’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,833
Closed -$209K 694
2025
Q1
$209K Sell
4,833
-726
-13% -$36.8K 0.01% 642
2024
Q4
$312K Sell
5,559
-154
-3% -$9.58K 0.02% 517
2024
Q3
$389K Sell
5,713
-1
-0% -$56 0.02% 461
2024
Q2
$241K Sell
5,714
-154
-3% -$8.47K 0.02% 544
2024
Q1
$405K Buy
5,868
+392
+7% +$24.8K 0.03% 421
2023
Q4
$405K Buy
5,476
+27
+0.5% +$1.77K 0.03% 388
2023
Q3
$372K Buy
5,449
+163
+3% +$13.8K 0.03% 374
2023
Q2
$496K Buy
5,286
+500
+10% +$39K 0.05% 325
2023
Q1
$325K Hold
4,786
0.03% 389
2022
Q4
$237K Buy
+4,786
New +$196K 0.03% 450
2022
Q2
Sell
-4,814
Closed -$337K 512
2022
Q1
$337K Sell
4,814
-305
-6% -$22.3K 0.04% 365
2021
Q4
$398K Buy
5,119
+50
+1% +$4.41K 0.05% 312
2021
Q3
$484K Buy
5,069
+530
+12% +$56K 0.08% 242
2021
Q2
$564K Buy
4,539
+421
+10% +$50.2K 0.09% 216
2021
Q1
$543K Sell
4,118
-57
-1% -$7.8K 0.12% 159
2020
Q4
$553K Hold
4,175
0.14% 130
2020
Q3
$426K Buy
4,175
+275
+7% +$23.7K 0.13% 133
2020
Q2
$339K Buy
3,900
+272
+7% +$21.7K 0.12% 117
2020
Q1
$210K Buy
3,628
+100
+3% +$8.12K 0.12% 117
2019
Q4
$326K Buy
3,528
+2,975
+538% +$262K 0.22% 63
2019
Q3
$50K Buy
+553
New +$63K 0.04% 151

Other funds holding EXAS

Strategic Blueprint's EXAS Position: Q2 2025 in Review

Strategic Blueprint sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 4,833 shares — an estimated $209K sold.

Strategic Blueprint first reported a position in EXAS in Q3 2019 and held it in 21 quarters. The position peaked at $564K in Q2 2021. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Strategic Blueprint reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Strategic Blueprint sold 4,833 Exact Sciences shares in Q2 2025, an estimated $209K.
  • Strategic Blueprint first reported a position in Exact Sciences in Q3 2019 and held it in 21 quarters.
  • Strategic Blueprint's Exact Sciences position peaked at $564K in Q2 2021.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Strategic Blueprint's 13F filing for Q2 2025, filed 30 Jul 2025.